Chia-Jung Busch (C-J Busch)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Locally Advanced

Squamous Cell Carcinoma

Obstructive Sleep Apnea

Top Venues

Medicina (Kaunas, Lithuania)

Healthcare (Basel, Switzerland)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Olaf Gil, Benjamin Fenske, Thomas Bremert, Marcus Vollmer, Christian Scharf, Chia-Jung Busch, Markus Blaurock
Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Olaf Gil, Benjamin Fenske, Thomas Bremert, Marcus Vollmer, Christian Scharf, Chia-Jung Busch, Markus Blaurock
Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Olaf Gil, Benjamin Fenske, Thomas Bremert, Marcus Vollmer, Christian Scharf, Chia-Jung Busch, Markus Blaurock
Prevalence of Obstructive Sleep Apnea in Head and Neck Squamous Cell Carcinoma Patients before and after Treatment. Medicina (Kaunas, Lithuania) 60 (2) (2024)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO 71 (2) (2023)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO 71 (2) (2023)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO 71 (2) (2023)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO 71 (2) (2023)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO 71 (2) (2023)
Oliver C Dziemba, Tina Brzoska, Friedrich Ihler, Chia-Jung Busch
[Suitability of determining percentage hearing loss for monitoring cochlear implant rehabilitation]. HNO (2023)
Tina Brzoska, Till Ittermann, Friedrich Ihler, Carmela Koch, Markus Blaurock, Robin Bülow, Henry Völzke, Chia-Jung Busch, Achim Georg Beule
Population Based Average Parotid Gland Volume and Prevalence of Incidental Tumors in T1-MRI. Healthcare (Basel, Switzerland) 10 (11) (2022)
Markus Blaurock, Chia-Jung Busch
[Chemotherapy and targeted therapy of head and neck squamous cell carcinomas at the 2021 ASCO meeting]. HNO 70 (4) (2022)
Lara Bußmann, Simon Laban, Claus Wittekindt, Carmen Stromberger, Silke Tribius, Nikolaus Möckelmann, Arne Böttcher, Christian Stephan Betz, Jens Peter Klussmann, Volker Budach, Adrian Muenscher, Chia-Jung Busch
Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC). BMC cancer 20 (1) (2020)
Henrike B Zech, Nikolaus Moeckelmann, Arne Boettcher, Adrian Muenscher, Mascha Binder, Eik Vettorazzi, Carsten Bokemeyer, Philippe Schafhausen, Christian S Betz, Chia-Jung Busch
Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma. Future oncology (London, England) 16 (36) (2020)
Chia-Jung Busch, J Girke, S Tribius, L Bussmann, R Knecht, P Schafhausen, B B Lörincz, A Münscher
Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 42 (6) (2017)